Literature DB >> 1695844

Antigenic role of single residues within the main immunogenic region of the nicotinic acetylcholine receptor.

I Papadouli1, S Potamianos, I Hadjidakis, E Bairaktari, V Tsikaris, C Sakarellos, M T Cung, M Marraud, S J Tzartos.   

Abstract

The target of most of the autoantibodies against the acetylcholine receptor (AChR) in myasthenic sera is the main immunogenic region (MIR) on the extracellular side of the AChR alpha-subunit. Binding of anti-MIR monoclonal antibodies (mAbs) has been recently localized between residues alpha 67 and alpha 76 of Torpedo californica electric organ (WNPADYGGIK) and human muscle (WNPDDYGGVK) AChR. In order to evaluate the contribution of each residue to the antigenicity of the MIR, we synthesized peptides corresponding to residues alpha 67-76 from Torpedo and human AChRs, together with 13 peptide analogues. Nine of these analogues had one residue of the Torpedo decapeptide replaced by L-alanine, three had a structure which was intermediate between those of the Torpedo and human alpha 67-76 decapeptides, and one had D-alanine in position 73. Binding studies employing six anti-MIR mAbs and all 15 peptides revealed that some residues (Asn68 and Asp71) are indispensable for binding by all mAbs tested, whereas others are important only for binding by some mAbs. Antibody binding was mainly restricted to residues alpha 68-74, the most critical sequence being alpha 68-71. Fish electric organ and human MIR form two distinct groups of strongly overlapping epitopes. Some peptide analogues enhanced mAb binding compared with Torpedo and human peptides, suggesting that the construction of a very antigenic MIR is feasible.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695844      PMCID: PMC1131559          DOI: 10.1042/bj2690239

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Location of antigenic determinants on primary sequences of subunits of nicotinic acetylcholine receptor by peptide mapping.

Authors:  M Ratnam; P B Sargent; V Sarin; J L Fox; D L Nguyen; J Rivier; M Criado; J Lindstrom
Journal:  Biochemistry       Date:  1986-05-06       Impact factor: 3.162

2.  Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera.

Authors:  F Heidenreich; A Vincent; A Roberts; J Newsom-Davis
Journal:  Autoimmunity       Date:  1988       Impact factor: 2.815

3.  Epitope mapping employing antibodies raised against short synthetic peptides: a study of the nicotinic acetylcholine receptor.

Authors:  A Maelicke; R Plümer-Wilk; G Fels; S R Spencer; M Engelhard; D Veltel; B M Conti-Tronconi
Journal:  Biochemistry       Date:  1989-02-07       Impact factor: 3.162

Review 4.  Myasthenia gravis.

Authors:  J Lindstrom; D Shelton; Y Fujii
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

5.  Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor.

Authors:  S Tzartos; L Langeberg; S Hochschwender; J Lindstrom
Journal:  FEBS Lett       Date:  1983-07-11       Impact factor: 4.124

6.  Interaction of nicotinic acetylcholine receptor with two monoclonal antibodies recognizing different epitopes.

Authors:  M A Chinchetru; J Marquez; J C Garcia-Borron; D P Richman; M Martinez-Carrion
Journal:  Biochemistry       Date:  1989-05-16       Impact factor: 3.162

7.  Two-dimensional 1H-NMR study of synthetic peptides containing the main immunogenic region of the Torpedo acetylcholine receptor.

Authors:  M T Cung; M Marraud; I Hadjidakis; E Bairaktari; C Sakarellos; A Kokla; S Tzartos
Journal:  Biopolymers       Date:  1989-01       Impact factor: 2.505

8.  Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis.

Authors:  V A Lennon; G E Griesmann
Journal:  Neurology       Date:  1989-08       Impact factor: 9.910

9.  Antigen-antibody interaction. Synthetic peptides define linear antigenic determinants recognized by monoclonal antibodies directed to the cytoplasmic carboxyl terminus of rhodopsin.

Authors:  R S Hodges; R J Heaton; J M Parker; L Molday; R S Molday
Journal:  J Biol Chem       Date:  1988-08-25       Impact factor: 5.157

10.  Structure and transmembrane nature of the acetylcholine receptor in amphibian skeletal muscle as revealed by cross-reacting monoclonal antibodies.

Authors:  P B Sargent; B E Hedges; L Tsavaler; L Clemmons; S Tzartos; J M Lindstrom
Journal:  J Cell Biol       Date:  1984-02       Impact factor: 10.539

View more
  7 in total

1.  Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.

Authors:  N Venkatesh; S H Im; M Balass; S Fuchs; E Katchalski-Katzir
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 2.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 3.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

4.  Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics.

Authors:  G Guichard; N Benkirane; G Zeder-Lutz; M H van Regenmortel; J P Briand; S Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

5.  Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications.

Authors:  Kaori Noridomi; Go Watanabe; Melissa N Hansen; Gye Won Han; Lin Chen
Journal:  Elife       Date:  2017-04-25       Impact factor: 8.140

6.  The tyrosine phosphorylation site of the acetylcholine receptor beta subunit is located in a highly immunogenic epitope implicated in channel function: antibody probes for beta subunit phosphorylation and function.

Authors:  S J Tzartos; C Valcana; R Kouvatsou; A Kokla
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

Review 7.  Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system.

Authors:  Nese Sinmaz; Tina Nguyen; Fiona Tea; Russell C Dale; Fabienne Brilot
Journal:  J Neuroinflammation       Date:  2016-08-30       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.